CytoDyn Inc. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
CytoDyn Inc. (CYDY) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 2.35 million shares for the 12-month period ending 2025-05-31, per its S-1 filed 2026-04-22.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-04-22
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month |
|---|---|---|
| 2025-05-31 | 2.35M shares S-1 · filed 2026-04-22 | |
| 2025-02-28 | 625.00K shares 10-Q · filed 2025-04-14 |